239 related articles for article (PubMed ID: 30088779)
1. Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.
Popescu I; Mannem H; Winters SA; Hoji A; Silveira F; McNally E; Pipeling MR; Lendermon EA; Morrell MR; Pilewski JM; Hanumanthu VS; Zhang Y; Gulati S; Shah PD; Iasella CJ; Ensor CR; Armanios M; McDyer JF
Am J Respir Crit Care Med; 2019 Feb; 199(3):362-376. PubMed ID: 30088779
[TBL] [Abstract][Full Text] [Related]
2. Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications.
Hannan SJ; Iasella CJ; Sutton RM; Popescu ID; Koshy R; Burke R; Chen X; Zhang Y; Pilewski JM; Hage CA; Sanchez PG; Im A; Farah R; Alder JK; McDyer JF
Am J Transplant; 2023 Oct; 23(10):1590-1602. PubMed ID: 37392813
[TBL] [Abstract][Full Text] [Related]
3. Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.
Pipeling MR; John ER; Orens JB; Lechtzin N; McDyer JF
J Infect Dis; 2011 Dec; 204(11):1663-71. PubMed ID: 22021622
[TBL] [Abstract][Full Text] [Related]
4. Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated disease.
Alder JK; Sutton RM; Iasella CJ; Nouraie M; Koshy R; Hannan SJ; Chan EG; Chen X; Zhang Y; Brown M; Popescu I; Veatch M; Saul M; Berndt A; Methé BA; Morris A; Pilewski JM; Sanchez PG; Morrell MR; Shapiro SD; Lindell KO; Gibson KF; Kass DJ; McDyer JF
J Heart Lung Transplant; 2022 May; 41(5):654-663. PubMed ID: 34933798
[TBL] [Abstract][Full Text] [Related]
5. Lung transplant recipients with idiopathic pulmonary fibrosis have impaired alloreactive immune responses.
Wang P; Leung J; Lam A; Lee S; Calabrese DR; Hays SR; Golden JA; Kukreja J; Singer JP; Wolters PJ; Tang Q; Greenland JR
J Heart Lung Transplant; 2022 May; 41(5):641-653. PubMed ID: 34924263
[TBL] [Abstract][Full Text] [Related]
6. IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control.
Popescu I; Pipeling MR; Mannem H; Shah PD; Orens JB; Connors M; Migueles SA; McDyer JF
J Immunol; 2016 Jan; 196(2):877-90. PubMed ID: 26663780
[TBL] [Abstract][Full Text] [Related]
7. Impact of age and telomere length on circulating T cells and rejection risk after lung transplantation for idiopathic pulmonary fibrosis.
Snyder ME; Anderson MR; Benvenuto LJ; Sutton RM; Bondonese A; Koshy R; Burke R; Clifford S; Craig A; Iasella CJ; Hannan SJ; Popescu I; Zhang Y; Sanchez PG; Alder JK; McDyer JF
J Heart Lung Transplant; 2023 Dec; 42(12):1666-1677. PubMed ID: 37544465
[TBL] [Abstract][Full Text] [Related]
8. T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.
Popescu I; Pipeling MR; Shah PD; Orens JB; McDyer JF
J Immunol; 2014 Dec; 193(11):5709-5722. PubMed ID: 25339676
[TBL] [Abstract][Full Text] [Related]
9. Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.
Shlobin OA; West EE; Lechtzin N; Miller SM; Borja M; Orens JB; Dropulic LK; McDyer JF
J Immunol; 2006 Feb; 176(4):2625-34. PubMed ID: 16456025
[TBL] [Abstract][Full Text] [Related]
10. Association of Premature Immune Aging and Cytomegalovirus After Solid Organ Transplant.
Higdon LE; Gustafson CE; Ji X; Sahoo MK; Pinsky BA; Margulies KB; Maecker HT; Goronzy J; Maltzman JS
Front Immunol; 2021; 12():661551. PubMed ID: 34122420
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.
Avery RK; Silveira FP; Benedict K; Cleveland AA; Kauffman CA; Schuster MG; Dubberke ER; Husain S; Paterson DL; Chiller T; Pappas P
Transpl Infect Dis; 2018 Jun; 20(3):e12877. PubMed ID: 29512935
[TBL] [Abstract][Full Text] [Related]
12. Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors.
Belga S; Hussain S; Avery RK; Nauroz Z; Durand CM; King EA; Massie A; Segev DL; Connor AE; Bush EL; Levy RD; Shah P; Werbel WA
J Heart Lung Transplant; 2024 Apr; 43(4):615-625. PubMed ID: 38061469
[TBL] [Abstract][Full Text] [Related]
13. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
14. Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.
Pipeling MR; West EE; Osborne CM; Whitlock AB; Dropulic LK; Willett MH; Forman M; Valsamakis A; Orens JB; Moller DR; Lechtzin N; Migueles SA; Connors M; McDyer JF
J Immunol; 2008 Jul; 181(1):546-56. PubMed ID: 18566421
[TBL] [Abstract][Full Text] [Related]
15. Acute Hypoxemic Respiratory Failure and Native Lung Idiopathic Pulmonary Fibrosis Exacerbation in Single-lung Transplant Patients with Cytomegalovirus Disease: A Case Series.
Marron RM; Vega Sanchez ME; Clauss H; Mamary AJ
Transplant Proc; 2019 Dec; 51(10):3391-3394. PubMed ID: 31733804
[TBL] [Abstract][Full Text] [Related]
16. Active CMV infection before lung transplantation: risk factors and clinical implications.
Milstone AP; Brumble LM; Loyd JE; Ely EW; Roberts JR; Pierson RN; Dummer JS
J Heart Lung Transplant; 2000 Aug; 19(8):744-50. PubMed ID: 10967267
[TBL] [Abstract][Full Text] [Related]
17. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
[TBL] [Abstract][Full Text] [Related]
18. Telomeres in Interstitial Lung Disease: The Short and the Long of It.
Courtwright AM; El-Chemaly S
Ann Am Thorac Soc; 2019 Feb; 16(2):175-181. PubMed ID: 30540921
[TBL] [Abstract][Full Text] [Related]
19. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment.
Fernández-Ruiz M; Giménez E; Vinuesa V; Ruiz-Merlo T; Parra P; Amat P; Montejo M; Paez-Vega A; Cantisán S; Torre-Cisneros J; Fortún J; Andrés A; San Juan R; López-Medrano F; Navarro D; Aguado JM;
Clin Microbiol Infect; 2019 Mar; 25(3):381.e1-381.e10. PubMed ID: 29803844
[TBL] [Abstract][Full Text] [Related]
20. From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis.
van Batenburg AA; Kazemier KM; van Oosterhout MFM; van der Vis JJ; van Es HW; Grutters JC; Goldschmeding R; van Moorsel CHM
PLoS One; 2020; 15(1):e0226785. PubMed ID: 31910222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
